Industry News

Aug 28, 2017
By BioPharm International Editors
FDA noted in a recent inspection that US Stem Cell Clinic was processing and administering stem cell treatments that were neither reviewed nor approved by the agency.
Aug 28, 2017
By BioPharm International Editors
FDA halts unproved stem-cell cancer treatments administered to California patients, which was derived from a commercially unavailable military-grade vaccine.
Aug 28, 2017
High-priority issues requiring immediate attention leave little time for Congress to consider drug access proposals that have limited bipartisan support.
Aug 24, 2017
By BioPharm International Editors
FDA’S CDER and ORA have entered into a concept of operations agreement to integrate facility evaluations and inspections for human drugs.
Aug 24, 2017
By BioPharm International Editors
An industry workgroup of pharmaceutical companies, toxicologists, and data experts plans to unveil the early results of a data sharing project designed to enhance the safety of drug substances.
Aug 24, 2017
By BioPharm International Editors
The US Pharmacopeial Convention is hosting a variety of workshops in Autumn 2017 on a wide range of topics including continuing education, bioassays, and peptides.
Aug 24, 2017
By BioPharm International Editors
With £4.5 million (US$5.8 million) in funding, the consortium is tasked with developing a new automated continuous biologics purification unit to make biologic drug manufacturing more efficient.
Aug 24, 2017
By BioPharm International Editors
The company is voluntarily recalling the products because of potential contamination with Burkholderia cepacia.
Aug 23, 2017
By BioPharm International Editors
FDA sent a warning letter to Bicooya Cosmetics Limited after inspectors found rodent feces at the company’s Zhejiang, China facility.
Aug 23, 2017
By BioPharm International Editors
FDA has signed a confidentiality commitment with the European Commission and the European Medicines Agency that allows FDA to share confidential information with EU regulations.
native1_300x100
lorem ipsum